RNU6-902P

Across TCGA pan-cancer cohorts, RNU6-902P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU6-902P data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher RNU6-902P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-902P expression acts as an unfavorable survival marker, although some lineages such as STAD and HNSC show a favorable association.

LGG, STAD, and UCEC are the cancer types where RNU6-902P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	DFS	Tertile	All	0.583	0.759	<.001	42	view →
STAD	DFS	Tertile	IV	0.765	0.274	.035	36	view →
UCEC	OS	Tertile	All	0.331	0.687	.008	24	view →
READ	OS	Tertile	III,IV	0.287	0.772	.030	18	view →
HNSC	OS	Tertile	All	0.948	0.743	.020	12	view →
UVM	DFS	Tertile	III,IV	0.032	0.727	<.001	9	view →
SKCM	OS	Tertile	All	0.637	0.283	.007	9	view →
LUSC	OS	Tertile	II,III,IV	0.489	0.803	.033	6	view →
KIRP	DFS	Tertile	All	0.797	0.926	.009	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU6-902P–LGG (DFS)

Open the LGG breakdown →